Trial intelligence / Profile preview

MPA vs. Ganirelix in Oocyte Donors

NCT03300960Phase 3Completed

Sponsor
IVI
Start
Oct 2017
Primary completion
Jun 2019
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of medroxyprogesterone acetate in infertility, sponsored by IVI. Started Oct 2017; status: completed.

02

Drugs

medroxyprogesterone acetate
03

Conditions

infertility

Beyond the preview

Go deeper on NCT03300960.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03300960.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call